Found: 12
Select item for more details and to access through your institution.
Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID‐19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical Trial.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 6, p. 1, doi. 10.1111/irv.13338
- By:
- Publication type:
- Article
Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 2, p. e2354991, doi. 10.1001/jamanetworkopen.2023.54991
- By:
- Publication type:
- Article
Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 8, p. 1403, doi. 10.1093/cid/ciac933
- By:
- Publication type:
- Article
ENSITRELVIR FOR MILD-TO-MODERATE COVID-19: PHASE 3 PART OF PHASE 2/3 STUDY.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 68
- By:
- Publication type:
- Article
S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 679, p. 1, doi. 10.1126/scitranslmed.abq4064
- By:
- Publication type:
- Article
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 2984, doi. 10.1093/jac/dkac257
- By:
- Publication type:
- Article
Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 1, p. 111, doi. 10.3390/v14010111
- By:
- Publication type:
- Article
MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84882-7
- By:
- Publication type:
- Article
TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 3, p. 384, doi. 10.3390/v13030384
- By:
- Publication type:
- Article
SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 1, p. 1, doi. 10.1371/journal.ppat.1009233
- By:
- Publication type:
- Article
Inhibition of dengue virus infection by 1-stearoyl-2-arachidonoyl-phosphatidylinositol in vitro.
- Published in:
- FASEB Journal, 2019, v. 33, n. 12, p. 13866, doi. 10.1096/fj.201901095RR
- By:
- Publication type:
- Article
A hybrid strategy using global analysis of oxidized fatty acids and bioconversion by Bacillus circulans.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2016, v. 30, n. 6, p. 751, doi. 10.1002/rcm.7504
- By:
- Publication type:
- Article